Observational studyInternational journal of cancer2026
Inflammatory proteins in pre-diagnosis versus at-diagnosis samples associated with differentiated thyroid cancer.
Observational study in International journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Inflammation is a hallmark of cancer, but its role in thyroid cancer is unclear. We examined the association between 92 inflammatory proteins measured by Olink Target 96 and differentiated thyroid cancer in samples collected 1-8 years before diagnosis (pre-diagnosis) and <1 year before (at-diagnosis) from 69 thyroid cancer cases and 69 matched controls matched by sex, age, race/ethnicity, BMI, and sample collection year from BioMe, a medical record-linked biobank. The at-diagnosis group included 46 cases and 46 controls, while the pre-diagnosis group included 23 cases and 23 controls. The association between the inflammatory proteins and thyroid cancer was assessed using logistic and generalized weighted quantile sum regressions. Eleven inflammatory proteins were negatively associated with thyroid cancer diagnosis: one in the at-diagnosis group (OPG) and ten in the pre-diagnosis group (CCL20, CXCL6, FGF-21, IL20-RA, TSLP, CST5, IL7, MCP-3, MMP-1, and TNF). There was a negative association between the mixture effect of the proteins (constrained in the negative direction) and thyroid cancer diagnosis only in the pre-diagnosis group. Overall, we found a difference in inflammatory proteins negatively associated with thyroid cancer in the at- versus the pre-diagnosis group. These findings highlight that inflammation potentially has a dual role in thyroid carcinogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.